JP2024511832A - Ｓｔｉｎｇアゴニストとして有用な新規化合物およびその使用 - Google Patents
Ｓｔｉｎｇアゴニストとして有用な新規化合物およびその使用 Download PDFInfo
- Publication number
- JP2024511832A JP2024511832A JP2023560282A JP2023560282A JP2024511832A JP 2024511832 A JP2024511832 A JP 2024511832A JP 2023560282 A JP2023560282 A JP 2023560282A JP 2023560282 A JP2023560282 A JP 2023560282A JP 2024511832 A JP2024511832 A JP 2024511832A
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- pharmaceutically acceptable
- acceptable salt
- membered
- deuterium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D495/14—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (17)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2021/083783 | 2021-03-30 | ||
| CN2021083783 | 2021-03-30 | ||
| CNPCT/CN2021/090945 | 2021-04-29 | ||
| CN2021090945 | 2021-04-29 | ||
| CN2021111479 | 2021-08-09 | ||
| CNPCT/CN2021/111479 | 2021-08-09 | ||
| CN2021128942 | 2021-11-05 | ||
| CNPCT/CN2021/128942 | 2021-11-05 | ||
| CNPCT/CN2021/130097 | 2021-11-11 | ||
| CN2021130097 | 2021-11-11 | ||
| CNPCT/CN2021/138806 | 2021-12-16 | ||
| CN2021138806 | 2021-12-16 | ||
| CN2021143043 | 2021-12-30 | ||
| CNPCT/CN2021/143043 | 2021-12-30 | ||
| CNPCT/CN2022/071548 | 2022-01-12 | ||
| CN2022071548 | 2022-01-12 | ||
| PCT/CN2022/083557 WO2022206725A1 (en) | 2021-03-30 | 2022-03-29 | Novel compounds useful as sting agonists and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024511832A true JP2024511832A (ja) | 2024-03-15 |
| JP2024511832A5 JP2024511832A5 (https=) | 2025-04-07 |
Family
ID=83457956
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560282A Pending JP2024511832A (ja) | 2021-03-30 | 2022-03-29 | Ｓｔｉｎｇアゴニストとして有用な新規化合物およびその使用 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20240116909A1 (https=) |
| EP (1) | EP4313962A4 (https=) |
| JP (1) | JP2024511832A (https=) |
| CN (1) | CN117203194A (https=) |
| AR (1) | AR125608A1 (https=) |
| TW (1) | TW202302579A (https=) |
| UY (1) | UY39705A (https=) |
| WO (1) | WO2022206725A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN118524854A (zh) * | 2021-12-17 | 2024-08-20 | 北京加科思新药研发有限公司 | 包含可用作sting激动剂的新型化合物的化合物-连接基构建体及其用途 |
| WO2024032782A1 (en) * | 2022-08-12 | 2024-02-15 | Jacobio Pharmaceuticals Co.Ltd. | Vaccine adjuvants and uses thereof |
| WO2026001915A1 (en) * | 2024-06-24 | 2026-01-02 | Jacobio Pharmaceuticals Co., Ltd. | Drug linker, conjugate thereof, and uses thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019195124A1 (en) * | 2018-04-03 | 2019-10-10 | Merck Sharp & Dohme Corp. | Benzothiophenes and related compounds as sting agonists |
| WO2019195063A1 (en) * | 2018-04-03 | 2019-10-10 | Merck Sharp & Dohme Corp. | Aza-benzothiophene compounds as sting agonists |
| WO2021014365A1 (en) * | 2019-07-22 | 2021-01-28 | Lupin Limited | Macrocyclic compounds as sting agonists and methods and uses thereof |
-
2022
- 2022-03-29 WO PCT/CN2022/083557 patent/WO2022206725A1/en not_active Ceased
- 2022-03-29 AR ARP220100748A patent/AR125608A1/es not_active Application Discontinuation
- 2022-03-29 EP EP22778907.0A patent/EP4313962A4/en active Pending
- 2022-03-29 JP JP2023560282A patent/JP2024511832A/ja active Pending
- 2022-03-29 CN CN202280023908.7A patent/CN117203194A/zh active Pending
- 2022-03-29 TW TW111112050A patent/TW202302579A/zh unknown
- 2022-03-29 US US18/284,897 patent/US20240116909A1/en active Pending
- 2022-03-29 UY UY0001039705A patent/UY39705A/es unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019195124A1 (en) * | 2018-04-03 | 2019-10-10 | Merck Sharp & Dohme Corp. | Benzothiophenes and related compounds as sting agonists |
| WO2019195063A1 (en) * | 2018-04-03 | 2019-10-10 | Merck Sharp & Dohme Corp. | Aza-benzothiophene compounds as sting agonists |
| WO2021014365A1 (en) * | 2019-07-22 | 2021-01-28 | Lupin Limited | Macrocyclic compounds as sting agonists and methods and uses thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN117203194A (zh) | 2023-12-08 |
| AR125608A1 (es) | 2023-08-02 |
| TW202302579A (zh) | 2023-01-16 |
| WO2022206725A1 (en) | 2022-10-06 |
| EP4313962A1 (en) | 2024-02-07 |
| US20240116909A1 (en) | 2024-04-11 |
| EP4313962A4 (en) | 2025-02-26 |
| UY39705A (es) | 2022-10-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2019416589B2 (en) | Heterocyclic compound intermediate, preparation method therefor and application thereof | |
| AU2019291794B2 (en) | Substituted naphthyridinone compounds useful as T cell activators | |
| CN116648452B (zh) | 作为kras抑制剂的杂环化合物的制备及其应用方法 | |
| AU2019201352B2 (en) | Bromodomain inhibitors | |
| AU2016282289B2 (en) | HPK1 inhibitors and methods of using same | |
| KR101862493B1 (ko) | Fgfr4 억제제로서의 고리-융합된 비시클릭 피리딜 유도체 | |
| CA3089639C (en) | Imidazo[1,2-c]pyrimidinyl compounds as prc2 inhibitors | |
| CA3221788A1 (en) | Substituted tetrahydrofuran-2-carboxamides as modulators of sodium channels | |
| CN113272303A (zh) | 嘧啶并五元氮杂环类衍生物、其制备方法及其在医药上的应用 | |
| JP7549597B2 (ja) | Ｅｅｄおよびｐｒｃ２調節物質としての大環状アゾロピリジン誘導体 | |
| JP2024511832A (ja) | Ｓｔｉｎｇアゴニストとして有用な新規化合物およびその使用 | |
| CA2935071A1 (en) | Piperidine-dione derivatives | |
| JP2011521968A (ja) | プリンｐｉ３ｋ阻害剤化合物および使用方法 | |
| ME02693B (me) | Piridinil i fuzionisani piridinil triazolon derivati | |
| JP7663968B2 (ja) | Ｗｄｒ５阻害剤及び調節剤 | |
| KR20200083528A (ko) | 파르네소이드 x 수용체 조정제로서의 스피로시클릭 화합물 | |
| AU2012261077A1 (en) | 2-amino-3-(imidazol-2-yl)-pyridin-4-one derivatives and their use as VEGF receptor kinase inhibitors | |
| CN115873000B (zh) | 异喹啉酮类及喹唑啉酮类化合物及其组合物和用途 | |
| US20240199548A1 (en) | Novel compounds useful as sting agonists and uses thereof | |
| JP7710756B2 (ja) | Ｃｔｌａ－４低分子分解剤及びその使用 | |
| CN119677717A (zh) | 用于治疗trpm3介导的病症的吲哚嗪衍生物 | |
| JP2008504332A (ja) | ドーパミンｄ３受容体に対してアフィニティーを有する化合物およびその医薬における使用 | |
| JP2025518048A (ja) | Ｔｒｐｍ３媒介性障害を治療するためのインダゾール誘導体 | |
| CN120590414A (zh) | 一类含氮杂环类化合物、制备方法和用途 | |
| JP2025512951A (ja) | Ｇｐｒ３５調節因子及びその使用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250328 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20250328 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20251216 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20251211 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20260313 |